Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 5881 AL 5895

Concise review: Can stem cells be used to treat or model Alzheimer's disease?

Chen WW, Blurton-Jones M.

Stem Cells. 2012 Dec;30(12):2612-8. doi: 10.1002/stem.1240.

Animal models of Alzheimer disease

LaFerla FM, Green KN.

Cold Spring Harb Perspect Med. 2012 Nov 1;2(11):a006320. doi: 10.1101/cshperspect.a006320.

Na⁺-K⁺-ATPase, a potent neuroprotective modulator against Alzheimer disease

Zhang LN, Sun YJ, Pan S, Li JX, Qu YE, Li Y, Wang YL, Gao ZB.

Fundam Clin Pharmacol. 2013 Feb;27(1):96-103. doi: 10.1111/fcp.12000. Epub 2012 Oct 3.

Effects of pharmacological agents, sleep deprivation, hypoxia and transcranial magnetic stimulation on electroencephalographic rhythms in rodents: towards translational challenge models for drug discovery in Alzheimer's disease

Babiloni C, Infarinato F, Aujard F, Bastlund JF, Bentivoglio M, Bertini G, Del Percio C, Fabene PF, Forloni G, Herrero Ezquerro MT, Noè FM, Pifferi F, Ros-Bernal F, Christensen DZ, Dix S, Richardson JC, Lamberty Y, Drinkenburg W, Rossini PM.

Clin Neurophysiol. 2013 Mar;124(3):437-51. doi: 10.1016/j.clinph.2012.07.023. Epub 2012 Oct 4.

Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain

Sultana R, Perluigi M, Butterfield DA.

Free Radic Biol Med. 2013 Sep;62:157-169. doi: 10.1016/j.freeradbiomed.2012.09.027. Epub 2012 Oct 5.

Response to rivastigmine transdermal patch or memantine plus rivastigmine patch is affected by apolipoprotein E genotype in Alzheimer patients

Han HJ, Kim BC, Lee JY, Ryu SH, Na HR, Yoon SJ, Park HY, Shin JH, Cho SJ, Yi HA, Choi MS, Heo JH, Park KW, Kim KK, Choi SH.

Dement Geriatr Cogn Disord. 2012;34(3-4):167-73. doi: 10.1159/000342927. Epub 2012 Oct 5.

Rivastigmine dermal patch solves eating problems in an individual with advanced Alzheimer's disease

Uwano C, Suzuki M, Aikawa T, Ebihara T, Une K, Tomita N, Kosaka Y, Okinaga S, Furukawa K, Arai H, Ohrui T.

J Am Geriatr Soc. 2012 Oct;60(10):1979-80. doi: 10.1111/j.1532-5415.2012.04182.x.

Alzheimer disease: what new evidence shows

Uriri-Glover J, McCarthy M, Cesarotti E.

Nurs Manage. 2012 Nov;43(11):26-31; quiz 31-2. doi: 10.1097/01.NUMA.0000421671.10723.ad.

Pathogenesis and disease-modifying therapy in Alzheimer's disease: the flat line of progress

Castellani RJ, Perry G.

Arch Med Res. 2012 Nov;43(8):694-8. doi: 10.1016/j.arcmed.2012.09.009. Epub 2012 Oct 16.

Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer's disease patients

Babiloni C, Del Percio C, Bordet R, Bourriez JL, Bentivoglio M, Payoux P, Derambure P, Dix S, Infarinato F, Lizio R, Triggiani AI, Richardson JC, Rossini PM.

Clin Neurophysiol. 2013 May;124(5):837-50. doi: 10.1016/j.clinph.2012.09.017. Epub 2012 Oct 23.

Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's disease

Gauthier S, Molinuevo JL.

Alzheimers Dement. 2013 May;9(3):326-31. doi: 10.1016/j.jalz.2011.11.005. Epub 2012 Oct 27.

Drug repositioning for Alzheimer's disease

Corbett A, Pickett J, Burns A, Corcoran J, Dunnett SB, Edison P, Hagan JJ, Holmes C, Jones E, Katona C, Kearns I, Kehoe P, Mudher A, Passmore A, Shepherd N, Walsh F, Ballard C.

Nat Rev Drug Discov. 2012 Nov;11(11):833-46. doi: 10.1038/nrd3869.

Cholesterol and Alzheimer's disease: a still poorly understood correlation

Ricciarelli R, Canepa E, Marengo B, Marinari UM, Poli G, Pronzato MA, Domenicotti C.

IUBMB Life. 2012 Dec;64(12):931-5. doi: 10.1002/iub.1091. Epub 2012 Nov 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias